RIBOMIC None
RIBOMIC is a company that creates pharmaceutical drugs using RNA aptamers, which are molecularly targeted. Their co-discovery division earns money from alliance partners who share research expenses for the aptamer pharmaceutical business.
Estimated Revenue:
JPY 65 million
Headquarters:
Minato, Chiba, Japan